1-3 of 3
Thomas Schleier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Assessment of CDR101 - a BCMAxCD3xPD-L1 Trispecific Antibody with Superior Anti-Tumor Efficacy

Melissa Vrohlings, Jan Müller, Stephanie Jungmichel, David Senn, Anna Bianca Howald, Thomas Schleier, Fabian Scheifele, Severin Wendelspiess, Philipp Richle, Hannes Merten, Daniel Lenherr-Frey, Christian Leisner, Markus G Manz, Leonardo J. Borras
Journal: Blood
Blood (2021) 138 (Supplement 1): 1583.
https://doi.org/10.1182/blood-2021-152160
Published: 2021
Journal Articles

Local Activator and T Cell Engager (αBCMA x αPD-L1 x αCD3) with Enhanced Tumor Killing and Minimal Cytokine Release for the Treatment of Multiple Myeloma

Melissa Vrohlings, Stephanie Jungmichel, Jan Müller, David Senn, Thomas Schleier, Fabian Scheifele, Severin Wendelspiess, Christian Leisner, Maria-Theresa Krauth, MD, Ulrich Jaeger, MD, Leonardo J. Borras
Journal: Blood
Blood (2020) 136 (Supplement 1): 20.
https://doi.org/10.1182/blood-2020-136648
Published: 2020
Journal Articles

Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization

Maurice S. Brozzo, Saša Bjelić, Kaisa Kisko, Thomas Schleier, Veli-Matti Leppänen, Kari Alitalo, Fritz K. Winkler, Kurt Ballmer-Hofer
Journal: Blood
Blood (2012) 119 (7): 1781–1788.
https://doi.org/10.1182/blood-2011-11-390922
Published: 2012
Includes: Supplemental data